COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19.

ABSTRACT: COVID-19 has taken a huge toll on our lives over the last 3 years. Global initiatives put forward by all stakeholders are still in place to combat this pandemic and help us learn lessons for future ones. While the vaccine rollout was not able to curb the spread of the disease for all strains, the research community is still trying to develop effective therapeutics for COVID-19. Although Paxlovid and remdesivir have been approved by the FDA against COVID-19, they are not free of side effects. Therefore, the search for a therapeutic solution with high efficacy continues in the research community. To support this effort, in this latest version (v3) of COVID-19Base, we have summarized the biomedical entities linked to COVID-19 that have been highlighted in the scientific literature after the v

SUBMITTER: Basit SA 

PROVIDER: S-EPMC10025554 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature